Browse > Article

Isolated 3-Methylcrotonyl CoA Carboxylase Deficiency Detected by Newborn Screening Program Using Tandem Mass Spectrometry  

Kwak, Ju Young (Department of Pediatrics, Il Sin Christian Hospital)
Park, Jun Young (Department of Pediatrics, Il Sin Christian Hospital)
Nam, Kyung A (Department of Pediatrics, Il Sin Christian Hospital)
Son, Sang Hi (Department of Pediatrics, Il Sin Christian Hospital)
Seo, Son Sang (Department of Pediatrics, Il Sin Christian Hospital)
Publication Information
Clinical and Experimental Pediatrics / v.48, no.5, 2005 , pp. 561-564 More about this Journal
Abstract
Isolated deficiency of 3-methylcrotonyl CoA carboxylase is a rare disorder of the catabolic pathway for leucine and many patients have mild symptoms or no symptom. However, the introduction of tandem mass spectrometry in newborn screening has revealed an unexpectedly high incidence of this disorder. We report an asymptomatic premature infant with isolated 3-methylcrotonyl CoA carboxylase deficiency detected by newborn screening program using tandem mass spectrometry. She was born at preterm, 36 weeks of gestation and her birth weight was 1,912 gm. She was delivered by Cesarian section due to maternal preeclampsia and oligohydramnios. An elevation of 3-hydroxyisovalerylcarnitine in a blood sample obtained at Seven days was detected by tandem mass screening. Massively elevated excretion of 3-hydroxyisovalerate and 3-methylcrotonylglycine was detected in the urine collected at 15 days. L-carnitine(100 mg/kg/day) was administrated orally to correct sencondary carnitine deficiency. Carnitine is conjugated with metabolites, to decrease the potential toxic effects. She is asymptomatic to date, and her growth and development are within normal limits.
Keywords
3-Methylcrotonyl CoA carboxylase; Tandem mass spectrometry;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Elpeleg ON, Havkin S, Barash V, Jakobs C, Glick B, Shalev R. Familial hypotonia of childhood caused by isolated 3-methylcrotonyl-coenzyme A carboxylase deficiency. J Pediatr 1992;121:407-10   DOI   PUBMED
2 Steen C, Baumgartner ER, Duran M, Lehnert W, Suormala T, Fingerhut R, et al. Metabolic stroke in isolated 3-methylcrotonyl-CoA carboxylase deficiency. Eur J Pediatr 1999; 158:730-3   DOI   ScienceOn
3 Layward EM, Tanner MS, Pollitt RJ, Barlett K. Isolated biotin-resistant 3-methylcrotonyl-CoA carboxylase deficiency presenting as a Reye syndrome-like illness. J Inher Metab Dis 1989;12:339-40   DOI   ScienceOn
4 Rinaldo P, Schmidt-Sommerfeld E, Posca AP, Heales SJR, Woolf DA, Leonard JV. Effect of treatment with glycine and L-carnitine in medium-chain acyl-coenzyme A dehydrogenase deficiency. J Pediatr 1993;122:580-4   DOI   ScienceOn
5 Leonard JV, Seakins JWT, Bartlett K, Hyde J, Wilson J, Clayton B. Inherited disorders of 3-methylcrotonyl CoA carboxylation. Arch Dis Child 1981;56:53-9   DOI   ScienceOn
6 Gompertz D, Draffan GH, Watts JL, Hull D. Biotin-responsive-rnethvkrotonylglvcinuria. Lancet 1971;2:22-4   DOI   ScienceOn
7 JH Walter. L-carnitine. Arch Dis Child 1996;74:475-8   DOI   PUBMED   ScienceOn
8 Yap S, Monavari AA, Thornton P, Naughten E. Lateinfantile 3-methylcrotonyl-CoA carboxylase deficiency presenting as global developmental delay. J Inher Metab Dis 1998;21:175-176   DOI   ScienceOn
9 Lehnert W, Niederhoff H, Suormala T, Baumgartner Er, Isolated biotin-resistant 3-methylcrotonyl-CoA carboxylase deficiency: long-term outcome in a case with neonatal onset. Eur J Pediatr 1996;155:568-72
10 Beemer FA, Bartlett K, Duran M, Ghneim HK, Wadman SK, Bruinvis L, et al. Isolated biotin-resistant 3-methylcrotonyl-CoA carboxylase deficiency in two sibs. Eur J Pediatr 1982;138:351-4   DOI   ScienceOn
11 Van Hove JLK, Rutledge SL, Nada MA, Kahler SG, Millington D. 3-Hydroxyisovalerylcarnitine in 3-methylcrotonyl CoA carboxylase deficiency. J Inher Metab Dis 1995;18: 592-601   DOI   ScienceOn
12 Visser G, Suorrnala T, Smit P, Reijngoud D, Bink-Boelkens M, Niezen-Koning K, et al. 3-Methylcrotonyl-CoA carboxylase deficiency in an infant with cardiomyopathy, in her brother with developmental delay in their asymptomatic father. Eur J Pediatr 2000;159:901-4   DOI   ScienceOn
13 Pearson MA, Aleck KA, Heidenreich RA. Benign clinical presentation of 3-methylcrotonylglycinuria. J Inher Metab Dis 1995;18:640-1   DOI   ScienceOn
14 Gallardo ME, Desviat LR, Rodriguez JM, Esparza-Gordillo J, Perez-Cerda C, Perez B, et al. The molecular basis of 3-methylcrotonylglycinuria, a disorder of leucine catabolism. Am J Hum Genet 2001;68:334-46   DOI   ScienceOn
15 Eldjarn L, Lellum E, Stokke O, Pande H, Waaler PE. \beta-Hydroxyisovaleric aciduria and \beta--Methvlcrotonylglycinuria : a new inborn error of metabolism. Lancet 1970;5:521-2   DOI   ScienceOn
16 Kim SJ. Maternal metabolic disease detected by newborn screening program using tandem mass. Korean J Inher Metab Dis 2003;3:97-9
17 Bannwart C, Wermuth B, Baumgartner R, Suormala T, Wiesmann uN. Isolated biotin-resistant deficiency of 3methylcrotonyl-CoA carboxylase presenting as a clinically severe form in a newborn with fatal outcome. J Inher Metab Dis 1992;15:863-8   DOI   ScienceOn
18 Murayama K, Kimura M, Yamaguchi S, Shinka T, Kodama K. Isolated 3-methylcrotonyl-CoA carboxylase deficiency in a 15-year-old girl. Brain Dev 1997;19:303-5   DOI   ScienceOn
19 Ihara K, Kuromaru R, Inoue Y, Kuhara T, Matsumoto I, Yoshino M, et al. An asymptomatic infant with isolated 3-methylcrotonyl-coenzyme A carboxylase deficiency detected by newborn screening for maple syrup urine disease. Eur J Pediatr 1997;156:713-5   DOI   ScienceOn
20 Tsai MY, Johnson DD, Sweetman L, Berry SA. Two siblings with biotin-resistant 3-methylcrotonyl-coenzyme A carboxylase deficiency. J Pediatr 1989;115:110-3   DOI   PUBMED